Cargando…
Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases
Immune checkpoint inhibitor‐induced diabetes mellitus is a rare immune‐related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes.
Autores principales: | Fujiwara, Noriko, Watanabe, Mayu, Katayama, Akihiro, Noda, Yohei, Eguchi, Jun, Kataoka, Hitomi, Kagawa, Shunsuke, Wada, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424178/ https://www.ncbi.nlm.nih.gov/pubmed/34522382 http://dx.doi.org/10.1002/ccr3.4574 |
Ejemplares similares
-
Risk Factors for the Requirement of Antenatal Insulin Treatment in Gestational Diabetes Mellitus
por: Watanabe, Mayu, et al.
Publicado: (2016) -
Pemt Deficiency Ameliorates Endoplasmic Reticulum Stress in Diabetic Nephropathy
por: Watanabe, Mayu, et al.
Publicado: (2014) -
Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease
por: Kurose, Yuko, et al.
Publicado: (2013) -
Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2
por: Nunoue, Tomokazu, et al.
Publicado: (2021) -
Author Correction: Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2
por: Nunoue, Tomokazu, et al.
Publicado: (2021)